InvestorsHub Logo
Followers 4
Posts 409
Boards Moderated 0
Alias Born 10/28/2009

Re: Ecomike post# 344

Wednesday, 12/02/2009 3:32:33 PM

Wednesday, December 02, 2009 3:32:33 PM

Post# of 7747
BioMedReports has high hopes...

"Going on record very conservatively, after spending some time speaking to insiders and studying the company closely, we see this as an $8 to $10 stock in twelve to fifteen months," writes M.E. Garza of BioMedReports. "We continue to look for a very positive news flow from Cytrx and some key developments ahead."

The complete report is available now at BioMedReports.Com:

http://biomedreports.com/articles/most-popular/20026-cytrx-announces-that-fda-lifts-clinical-hold-of-arimoclomol.html